Literature DB >> 19146757

Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid.

F Brossier1, N Veziris, V Jarlier, W Sougakoff.   

Abstract

SETTING: We recently evaluated the Genotype MTBDR test for assessing Mycobacterium tuberculosis resistance to rifampicin (RMP) and isoniazid (INH) by detecting mutations in rpoB (codons 511-533) and katG (codon 315). A new version of the test, MTBDR plus, has been designed to also detect mutations in the regulatory region of inhA.
OBJECTIVE: To evaluate the performance of MTBDR plus over MTBDR.
RESULTS: In 113 isolates, MTBDR plus detected all 76 RMP-resistant (RMP-R) strains and all 64 INH-resistant (INH-R) strains with KatG-315 mutations, 59 of which displayed a high level of INH resistance. It also identified 18 strains undetectable by MTBDR, without mutation in KatG-315 but with a -15 C-->T mutation in the regulatory region of inhA, of which 15 displayed a low level of INH resistance. Thirteen INH-R strains, which mainly harboured mutations in KatG at positions other than 315, were undetected by MTBDR plus.
CONCLUSION: MTBDR plus retains the accuracy shown by MTBDR in detecting RMP resistance and is more sensitive in detecting INH resistance (86% vs. 67%), particularly at low levels (minimum inhibitory concentration<1 mg/l, 69% vs. 17%). The negative predictive value of the test (the probability of a strain with a wild-type test being susceptible to INH) is >98% when the rate of INH is <10%, as it is in France.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19146757

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  16 in total

1.  Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.

Authors:  Corinne Surcouf; Seiha Heng; Catherine Pierre-Audigier; Véronique Cadet-Daniel; Amine Namouchi; Alan Murray; Brigitte Gicquel; Bertrand Guillard
Journal:  BMC Infect Dis       Date:  2011-09-28       Impact factor: 3.090

2.  Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Authors:  Florence Brossier; Nicolas Veziris; Alexandra Aubry; Vincent Jarlier; Wladimir Sougakoff
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

3.  Epidemiology of molecular probes in Xpert MTB/RIF assay in Khyber Pakhtunkhwa, Pakistan.

Authors:  Anwar Sheed Khan; Muhammad Tahir Khan; Sajid Ali; Taj Ali Khan; Muhammad Qasim; Arif Malik; Sajid Ali; Wasim Sajjad; Qurrat Ul Ain; Muhammad Irfan
Journal:  Arch Microbiol       Date:  2021-02-27       Impact factor: 2.552

4.  Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia.

Authors:  Beatriz E Ferro; Pamela K García; Luisa Maria Nieto; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

5.  Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis.

Authors:  Aurélie Fillion; Alexandra Aubry; Florence Brossier; Aurélie Chauffour; Vincent Jarlier; Nicolas Veziris
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

6.  First-line drug resistance profiling of Mycobacterium tuberculosis: a machine learning approach.

Authors:  Stephanie J Müller; Rebone L Meraba; Gciniwe S Dlamini; Darlington S Mapiye
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

Review 7.  Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing.

Authors:  Ameeta S Kalokhe; Majid Shafiq; James C Lee; Susan M Ray; Yun F Wang; Beverly Metchock; Albert M Anderson; Minh Ly T Nguyen
Journal:  Am J Med Sci       Date:  2013-02       Impact factor: 2.378

8.  Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.

Authors:  Suporn Pholwat; Suzanne Stroup; Jean Gratz; Varittha Trangan; Suporn Foongladda; Happiness Kumburu; Saumu Pazia Juma; Gibson Kibiki; Eric Houpt
Journal:  Tuberculosis (Edinb)       Date:  2013-11-01       Impact factor: 3.131

9.  Evaluation of Geno Type MTBDRplus Line Probe Assay for Early Detection of Drug Resistance in Tuberculous Meningitis Patients in India.

Authors:  Renu Gupta; Rajeev Thakur; Prerna Gupta; Nupur Jalan; Suman Kushwaha; Meena Gupta; Piyush Gupta; Amitesh Aggarwal; Vikas Manchanda
Journal:  J Glob Infect Dis       Date:  2015 Jan-Mar

10.  Using Xpert MTB/RIF.

Authors:  Mark P Nicol; Andrew Whitelaw; Stevens Wendy
Journal:  Curr Respir Med Rev       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.